News
Analysts expect Sarepta Therapeutics to report an earnings per share (EPS) of $1.01. The announcement from Sarepta ...
I do not work for Big Pharma. I work in support of President Trump on the outside of the administration,’ Loomer tells The ...
2hOpinion
The New Republic on MSNElon Musk’s Worst Nightmare About DOGE Is Starting to Come TrueThe National Weather Service has received permission to hire hundreds of employees, CNN reported Tuesday. That includes 450 ...
2hOpinion
The New Republic on MSNLaura Loomer Is Getting a Taste of Her Own MedicineAs Laura Loomer wields a terrifying amount of power, other far-right influencers are accusing her of being a “plant.” ...
The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 ...
3h
The New Republic on MSNLaura Loomer’s New Influence Is Already Backfiring on HerAs Laura Loomer wields a terrifying amount of power, other far-right influencers are accusing her of being a “plant.” ...
After Loomer targeted surgeon general nominee and Kennedy ally Casey Means, Means’s brother, Calley, suggested that Loomer’s ...
The FDA is allowing Sarepta to resume shipments of Elevidys (delandistrogene moxeparvovec) to ambulatory patients with Duchenne muscular dystrophy.
From innovation in manufacturing to more-flexible regulation and better communication with payers, much needs to happen to ...
Since becoming Vertex's top scientist in 2015, Altshuler has helped the company become an industry powerhouse. He’ll depart ...
11h
AlterNet on MSN'Hidden hand': MAGA Republicans slam Laura Loomer as a Big Pharma 'plant'Bulwark reporter Will Sommer reports MAGA influencer Laura Loomer is drawing criticism from MAGA members who claim she’s ...
The FDA's top vaccine official is stepping down after just 3 months in a role that upset drug companies, patient groups and some political leaders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results